Synthetic Lethality in ERCC1-deficient Non-Small Cell Lung Cancer

被引:0
|
作者
Postel-Vinay, S. [1 ]
Bajrami, I. [2 ]
Friboulet, L. [1 ]
Jaco, I. [2 ]
Fontebasso, Y. [2 ]
Olaussen, K. A. [1 ]
Soria, J. C. [3 ]
Andre, F. [1 ]
Lord, C. J. [2 ]
Ashworth, A. [2 ]
机构
[1] Inst Gustave Roussy, INSERM, U981, F-94805 Villejuif, France
[2] Breakthrough Breast Canc Ctr, Inst Canc Res, London, England
[3] Univ Paris 11, Dept Med, Inst Gustave Roussy, Villejuif, France
关键词
D O I
10.1016/S0959-8049(12)72086-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
288
引用
收藏
页码:88 / 88
页数:1
相关论文
共 50 条
  • [21] THE VALUE OF RESEARCH FOR ERCC1 TESTING IN STAGE I NON-SMALL CELL LUNG CANCER
    Roth, J.
    Carlson, J. J.
    Steuten, L.
    Veenstra, D.
    VALUE IN HEALTH, 2011, 14 (03) : A1 - A1
  • [22] ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer
    Lee, K.
    Han, S.
    Min, H.
    Oh, D.
    Lee, S.
    Kim, D.
    Kim, Y.
    Kim, T.
    Heo, D.
    Bang, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] ERCC1 Is a Predictive Biomarker for Non-small Cell Lung Cancer But Is Antibody-dependent
    Okimoto, Tamio
    Tsubata, Yukari
    Tanino, Ryosuke
    Nakao, Mika
    Hotta, Takamasa
    Hamaguchi, Megumi
    Hamaguchi, Shunichi
    Araki, Asuka
    Isobe, Takeshi
    ANTICANCER RESEARCH, 2021, 41 (05) : 2653 - 2660
  • [24] Association of EGFR mutations with ERCC1 expression in non-small cell lung cancer.
    Liang, Wenhua
    Lin, Ziying
    Xu, Yutong
    Zhang, Yaxiong
    He, Jianxing
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [25] Inhibition of dUTPase Induces Synthetic Lethality with Thymidylate Synthase-Targeted Therapies in Non-Small Cell Lung Cancer
    Wilson, Peter M.
    LaBonte, Melissa J.
    Lenz, Heinz-Josef
    Mack, Philip C.
    Ladner, Robert D.
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (03) : 616 - 628
  • [26] Combined FLT3 and PARP inhibition induces synthetic lethality in non-small cell lung cancer cells
    Ryu, Hwani
    Kim, Hyo Jeong
    Song, Jie-Young
    Hwang, Sang-Gu
    Ahn, Jiyeon
    CANCER RESEARCH, 2020, 80 (16)
  • [27] Non-small cell lung cancers:: ERCC1, a therapeutic biomarker in view
    Benard, Jean
    BULLETIN DU CANCER, 2006, 93 (11) : 1086 - 1086
  • [28] Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients
    Park, So-Yeon
    Hong, Yun-Chul
    Kim, Jin-Hee
    Kwak, Seung-Min
    Cho, Jae-Hwa
    Lee, Hong-Lyeol
    Ryu, Jeong-Seon
    MEDICAL ONCOLOGY, 2006, 23 (04) : 489 - 498
  • [29] Expression of hENT1 and ERCC1 genes in tumor tissues non-small cell lung cancer
    Jia-Jia Wu
    Shun-Chang Jiao
    Asian Pacific Journal of Tropical Medicine, 2013, (11) : 908 - 911
  • [30] Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients
    So-Yeon Park
    Yun-Chul Hong
    Jin-Hee Kim
    Seung-Min Kwak
    Jae-Hwa Cho
    Hong-Lyeol Lee
    Jeong-Seon Ryu
    Medical Oncology, 2006, 23 : 489 - 498